S. Grammer

发表

In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes.

J. Streilein, S. Grammer, 1989, Journal of immunology.

Functional Dichotomy between Langerhans Cells that Present Antigen to Naive and to Memory/Effector T Lymphocytes

A. Demidem, J. Streilein, M. Vermeer, 1990, Immunological reviews.

Antigen presentation by splenic B cells: resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses.

H. Grey, J. Krieger, R. Chesnut, 1985, Journal of immunology.

P53 gene replacement for cancer--interactions with DNA damaging agents.

J. Roth, S. Swisher, R. Komaki, 2001, Acta oncologica.

Ia-specific mixed leukocyte reactive T cell hybridomas: analysis of their specificity by using purified class II MHC molecules in synthetic membrane system.

H. Grey, R. Chesnut, R. Kubo, 1986, Journal of immunology.

Gene therapy approaches for the management of non-small cell lung cancer.

J. Roth, S. Swisher, R. Komaki, 2001, Seminars in oncology.

T-lymphocyte-activating properties of epidermal antigen-presenting cells from normal and psoriatic skin: evidence that psoriatic epidermal antigen-presenting cells resemble cultured normal Langerhans cells.

A. Demidem, J. Taylor, J. Streilein, 1991, The Journal of investigative dermatology.

Effects of chloroquine on antigen-presenting functions of epidermal cells from normal and psoriatic skin.

A. Demidem, J. Taylor, J. Streilein, 1992, The Journal of investigative dermatology.

Mouse monoclonal antibody (WI-MN-1) against malignant melanoma.

D. Chang, A. Khan, S. Grammer, 1983, Cancer research.

Role of F4/80+ cells during induction of hapten-specific contact hypersensitivity.

J. Streilein, S. Grammer, T. Shimizu, 1995, Immunology.

Comparison of effects of transforming growth factor-beta and cyclosporin A on antigen-presenting cells of blood and epidermis.

A. Demidem, J. Taylor, J. Streilein, 1991, The Journal of investigative dermatology.

pH-dependent intracellular quenching of the indicator carboxy-SNARF-1

D. Leeper, S. Bobyock, C. Owen, 1992, Journal of Fluorescence.

Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.

J. Gu, F. Khuri, W. Hong, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Tumor suppressor gene therapy.

J. Roth, S. Grammer, 2003, Methods in molecular biology.

Tumor Suppressor Gene Replacement for Cancer

J. Roth, S. Grammer, 2005 .

Gene replacement therapy for non-small cell lung cancer: a review.

J. Roth, S. Grammer, 2004, Hematology/oncology clinics of North America.

Gene replacement strategies for treating non-small cell lung cancer.

J. Roth, S. Swisher, J. Nemunaitis, 2000, Seminars in radiation oncology.

Identification of an HSV-1/HSV-2 cross-reactive T cell determinant.

A. Sette, S. Colon, R. Chesnut, 1990, Journal of immunology.

Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells.

J. Streilein, S. Grammer, R. Dai, 1993, Journal of immunology.